nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—Fatigue—Ifosfamide—testicular cancer	0.00185	0.00185	CcSEcCtD
Glimepiride—Anaphylactic shock—Cisplatin—testicular cancer	0.00185	0.00185	CcSEcCtD
Glimepiride—Hypersensitivity—Bleomycin—testicular cancer	0.00185	0.00185	CcSEcCtD
Glimepiride—Hypoglycaemia—Doxorubicin—testicular cancer	0.00183	0.00183	CcSEcCtD
Glimepiride—Loss of consciousness—Etoposide—testicular cancer	0.00182	0.00182	CcSEcCtD
Glimepiride—Cerebrovascular accident—Doxorubicin—testicular cancer	0.00182	0.00182	CcSEcCtD
Glimepiride—Thrombocytopenia—Cisplatin—testicular cancer	0.00181	0.00181	CcSEcCtD
Glimepiride—Tachycardia—Cisplatin—testicular cancer	0.0018	0.0018	CcSEcCtD
Glimepiride—Asthenia—Bleomycin—testicular cancer	0.0018	0.0018	CcSEcCtD
Glimepiride—Convulsion—Etoposide—testicular cancer	0.0018	0.0018	CcSEcCtD
Glimepiride—Hyponatraemia—Doxorubicin—testicular cancer	0.00179	0.00179	CcSEcCtD
Glimepiride—Hypertension—Etoposide—testicular cancer	0.00179	0.00179	CcSEcCtD
Glimepiride—Pain in extremity—Doxorubicin—testicular cancer	0.00179	0.00179	CcSEcCtD
Glimepiride—Hyperhidrosis—Cisplatin—testicular cancer	0.00179	0.00179	CcSEcCtD
Glimepiride—Pruritus—Bleomycin—testicular cancer	0.00177	0.00177	CcSEcCtD
Glimepiride—Feeling abnormal—Ifosfamide—testicular cancer	0.00177	0.00177	CcSEcCtD
Glimepiride—Eosinophilia—Methotrexate—testicular cancer	0.00177	0.00177	CcSEcCtD
Glimepiride—Nausea—Vinblastine—testicular cancer	0.00176	0.00176	CcSEcCtD
Glimepiride—Anorexia—Cisplatin—testicular cancer	0.00176	0.00176	CcSEcCtD
Glimepiride—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00175	0.00175	CcSEcCtD
Glimepiride—Hypotension—Cisplatin—testicular cancer	0.00173	0.00173	CcSEcCtD
Glimepiride—Hypersensitivity—Dactinomycin—testicular cancer	0.00172	0.00172	CcSEcCtD
Glimepiride—Confusional state—Etoposide—testicular cancer	0.00171	0.00171	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.0017	0.0017	CcSEcCtD
Glimepiride—Urticaria—Ifosfamide—testicular cancer	0.0017	0.0017	CcSEcCtD
Glimepiride—Abdominal pain—Ifosfamide—testicular cancer	0.00169	0.00169	CcSEcCtD
Glimepiride—Pancytopenia—Methotrexate—testicular cancer	0.00169	0.00169	CcSEcCtD
Glimepiride—Anaphylactic shock—Etoposide—testicular cancer	0.00169	0.00169	CcSEcCtD
Glimepiride—Abdominal distension—Epirubicin—testicular cancer	0.00168	0.00168	CcSEcCtD
Glimepiride—Asthenia—Dactinomycin—testicular cancer	0.00168	0.00168	CcSEcCtD
Glimepiride—Influenza—Epirubicin—testicular cancer	0.00167	0.00167	CcSEcCtD
Glimepiride—Paraesthesia—Cisplatin—testicular cancer	0.00166	0.00166	CcSEcCtD
Glimepiride—Thrombocytopenia—Etoposide—testicular cancer	0.00166	0.00166	CcSEcCtD
Glimepiride—Tachycardia—Etoposide—testicular cancer	0.00165	0.00165	CcSEcCtD
Glimepiride—Eosinophilia—Epirubicin—testicular cancer	0.00165	0.00165	CcSEcCtD
Glimepiride—Dyspnoea—Cisplatin—testicular cancer	0.00165	0.00165	CcSEcCtD
Glimepiride—Hyperhidrosis—Etoposide—testicular cancer	0.00164	0.00164	CcSEcCtD
Glimepiride—Photosensitivity reaction—Methotrexate—testicular cancer	0.00163	0.00163	CcSEcCtD
Glimepiride—Angina pectoris—Epirubicin—testicular cancer	0.00163	0.00163	CcSEcCtD
Glimepiride—Anorexia—Etoposide—testicular cancer	0.00161	0.00161	CcSEcCtD
Glimepiride—Decreased appetite—Cisplatin—testicular cancer	0.00161	0.00161	CcSEcCtD
Glimepiride—Diarrhoea—Dactinomycin—testicular cancer	0.0016	0.0016	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Cisplatin—testicular cancer	0.0016	0.0016	CcSEcCtD
Glimepiride—Vomiting—Bleomycin—testicular cancer	0.0016	0.0016	CcSEcCtD
Glimepiride—Drowsiness—Methotrexate—testicular cancer	0.00159	0.00159	CcSEcCtD
Glimepiride—Pancytopenia—Epirubicin—testicular cancer	0.00159	0.00159	CcSEcCtD
Glimepiride—Hypotension—Etoposide—testicular cancer	0.00158	0.00158	CcSEcCtD
Glimepiride—Rash—Bleomycin—testicular cancer	0.00158	0.00158	CcSEcCtD
Glimepiride—Dermatitis—Bleomycin—testicular cancer	0.00158	0.00158	CcSEcCtD
Glimepiride—Hypersensitivity—Ifosfamide—testicular cancer	0.00158	0.00158	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.00158	0.00158	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.00158	0.00158	CcSEcCtD
Glimepiride—Abdominal distension—Doxorubicin—testicular cancer	0.00155	0.00155	CcSEcCtD
Glimepiride—Influenza—Doxorubicin—testicular cancer	0.00154	0.00154	CcSEcCtD
Glimepiride—Pollakiuria—Epirubicin—testicular cancer	0.00154	0.00154	CcSEcCtD
Glimepiride—Asthenia—Ifosfamide—testicular cancer	0.00154	0.00154	CcSEcCtD
Glimepiride—Eosinophilia—Doxorubicin—testicular cancer	0.00153	0.00153	CcSEcCtD
Glimepiride—Sweating—Methotrexate—testicular cancer	0.00152	0.00152	CcSEcCtD
Glimepiride—Photosensitivity reaction—Epirubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Glimepiride—Feeling abnormal—Cisplatin—testicular cancer	0.00152	0.00152	CcSEcCtD
Glimepiride—Paraesthesia—Etoposide—testicular cancer	0.00152	0.00152	CcSEcCtD
Glimepiride—Weight increased—Epirubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Glimepiride—Pruritus—Ifosfamide—testicular cancer	0.00152	0.00152	CcSEcCtD
Glimepiride—Dyspnoea—Etoposide—testicular cancer	0.00151	0.00151	CcSEcCtD
Glimepiride—Somnolence—Etoposide—testicular cancer	0.00151	0.00151	CcSEcCtD
Glimepiride—Angina pectoris—Doxorubicin—testicular cancer	0.0015	0.0015	CcSEcCtD
Glimepiride—Nausea—Bleomycin—testicular cancer	0.00149	0.00149	CcSEcCtD
Glimepiride—Drowsiness—Epirubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Glimepiride—Vomiting—Dactinomycin—testicular cancer	0.00149	0.00149	CcSEcCtD
Glimepiride—Agranulocytosis—Methotrexate—testicular cancer	0.00148	0.00148	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Glimepiride—Rash—Dactinomycin—testicular cancer	0.00148	0.00148	CcSEcCtD
Glimepiride—Decreased appetite—Etoposide—testicular cancer	0.00147	0.00147	CcSEcCtD
Glimepiride—Diarrhoea—Ifosfamide—testicular cancer	0.00147	0.00147	CcSEcCtD
Glimepiride—Pancytopenia—Doxorubicin—testicular cancer	0.00147	0.00147	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Etoposide—testicular cancer	0.00146	0.00146	CcSEcCtD
Glimepiride—Fatigue—Etoposide—testicular cancer	0.00146	0.00146	CcSEcCtD
Glimepiride—Jaundice—Epirubicin—testicular cancer	0.00145	0.00145	CcSEcCtD
Glimepiride—Hepatitis—Methotrexate—testicular cancer	0.00143	0.00143	CcSEcCtD
Glimepiride—Sweating—Epirubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Glimepiride—Pollakiuria—Doxorubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Glimepiride—Dizziness—Ifosfamide—testicular cancer	0.00142	0.00142	CcSEcCtD
Glimepiride—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Glimepiride—Weight increased—Doxorubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Glimepiride—Feeling abnormal—Etoposide—testicular cancer	0.0014	0.0014	CcSEcCtD
Glimepiride—Nausea—Dactinomycin—testicular cancer	0.00139	0.00139	CcSEcCtD
Glimepiride—Agranulocytosis—Epirubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Glimepiride—Gastrointestinal pain—Etoposide—testicular cancer	0.00138	0.00138	CcSEcCtD
Glimepiride—Drowsiness—Doxorubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Glimepiride—Visual impairment—Methotrexate—testicular cancer	0.00138	0.00138	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Glimepiride—Vomiting—Ifosfamide—testicular cancer	0.00136	0.00136	CcSEcCtD
Glimepiride—Hypersensitivity—Cisplatin—testicular cancer	0.00136	0.00136	CcSEcCtD
Glimepiride—Bradycardia—Epirubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Glimepiride—Rash—Ifosfamide—testicular cancer	0.00135	0.00135	CcSEcCtD
Glimepiride—Dermatitis—Ifosfamide—testicular cancer	0.00135	0.00135	CcSEcCtD
Glimepiride—Erythema multiforme—Methotrexate—testicular cancer	0.00135	0.00135	CcSEcCtD
Glimepiride—Urticaria—Etoposide—testicular cancer	0.00135	0.00135	CcSEcCtD
Glimepiride—Jaundice—Doxorubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Glimepiride—Abdominal pain—Etoposide—testicular cancer	0.00134	0.00134	CcSEcCtD
Glimepiride—Hepatitis—Epirubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Glimepiride—Asthenia—Cisplatin—testicular cancer	0.00133	0.00133	CcSEcCtD
Glimepiride—Sweating—Doxorubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Glimepiride—Visual impairment—Epirubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Glimepiride—Agranulocytosis—Doxorubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Glimepiride—Nausea—Ifosfamide—testicular cancer	0.00127	0.00127	CcSEcCtD
Glimepiride—Diarrhoea—Cisplatin—testicular cancer	0.00126	0.00126	CcSEcCtD
Glimepiride—Erythema multiforme—Epirubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Glimepiride—Bradycardia—Doxorubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Glimepiride—Hypersensitivity—Etoposide—testicular cancer	0.00125	0.00125	CcSEcCtD
Glimepiride—Erythema—Methotrexate—testicular cancer	0.00124	0.00124	CcSEcCtD
Glimepiride—Malnutrition—Methotrexate—testicular cancer	0.00124	0.00124	CcSEcCtD
Glimepiride—Hepatitis—Doxorubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Glimepiride—Asthenia—Etoposide—testicular cancer	0.00121	0.00121	CcSEcCtD
Glimepiride—Pruritus—Etoposide—testicular cancer	0.0012	0.0012	CcSEcCtD
Glimepiride—Arrhythmia—Epirubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Glimepiride—Visual impairment—Doxorubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Glimepiride—Vomiting—Cisplatin—testicular cancer	0.00118	0.00118	CcSEcCtD
Glimepiride—Vision blurred—Methotrexate—testicular cancer	0.00117	0.00117	CcSEcCtD
Glimepiride—Erythema multiforme—Doxorubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Glimepiride—Rash—Cisplatin—testicular cancer	0.00117	0.00117	CcSEcCtD
Glimepiride—Dermatitis—Cisplatin—testicular cancer	0.00116	0.00116	CcSEcCtD
Glimepiride—Malnutrition—Epirubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Glimepiride—Erythema—Epirubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Glimepiride—Diarrhoea—Etoposide—testicular cancer	0.00116	0.00116	CcSEcCtD
Glimepiride—Anaemia—Methotrexate—testicular cancer	0.00115	0.00115	CcSEcCtD
Glimepiride—Tension—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Glimepiride—Nervousness—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Glimepiride—Dizziness—Etoposide—testicular cancer	0.00112	0.00112	CcSEcCtD
Glimepiride—Leukopenia—Methotrexate—testicular cancer	0.00111	0.00111	CcSEcCtD
Glimepiride—Arrhythmia—Doxorubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Glimepiride—Nausea—Cisplatin—testicular cancer	0.0011	0.0011	CcSEcCtD
Glimepiride—Vision blurred—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Glimepiride—Convulsion—Methotrexate—testicular cancer	0.00108	0.00108	CcSEcCtD
Glimepiride—Vomiting—Etoposide—testicular cancer	0.00108	0.00108	CcSEcCtD
Glimepiride—Erythema—Doxorubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Glimepiride—Malnutrition—Doxorubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Glimepiride—Anaemia—Epirubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Glimepiride—Agitation—Epirubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Glimepiride—Rash—Etoposide—testicular cancer	0.00107	0.00107	CcSEcCtD
Glimepiride—Dermatitis—Etoposide—testicular cancer	0.00107	0.00107	CcSEcCtD
Glimepiride—Headache—Etoposide—testicular cancer	0.00106	0.00106	CcSEcCtD
Glimepiride—Tension—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Glimepiride—Nervousness—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Glimepiride—Leukopenia—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Glimepiride—Palpitations—Epirubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Glimepiride—Confusional state—Methotrexate—testicular cancer	0.00102	0.00102	CcSEcCtD
Glimepiride—Loss of consciousness—Epirubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Glimepiride—Anaphylactic shock—Methotrexate—testicular cancer	0.00101	0.00101	CcSEcCtD
Glimepiride—Vision blurred—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Glimepiride—Convulsion—Epirubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Glimepiride—Nausea—Etoposide—testicular cancer	0.00101	0.00101	CcSEcCtD
Glimepiride—Hypertension—Epirubicin—testicular cancer	0.001	0.001	CcSEcCtD
Glimepiride—Anaemia—Doxorubicin—testicular cancer	0.000995	0.000995	CcSEcCtD
Glimepiride—Thrombocytopenia—Methotrexate—testicular cancer	0.000993	0.000993	CcSEcCtD
Glimepiride—Agitation—Doxorubicin—testicular cancer	0.000989	0.000989	CcSEcCtD
Glimepiride—Anxiety—Epirubicin—testicular cancer	0.000987	0.000987	CcSEcCtD
Glimepiride—Hyperhidrosis—Methotrexate—testicular cancer	0.000981	0.000981	CcSEcCtD
Glimepiride—Dry mouth—Epirubicin—testicular cancer	0.000968	0.000968	CcSEcCtD
Glimepiride—Anorexia—Methotrexate—testicular cancer	0.000967	0.000967	CcSEcCtD
Glimepiride—Leukopenia—Doxorubicin—testicular cancer	0.000963	0.000963	CcSEcCtD
Glimepiride—Confusional state—Epirubicin—testicular cancer	0.000957	0.000957	CcSEcCtD
Glimepiride—Palpitations—Doxorubicin—testicular cancer	0.000951	0.000951	CcSEcCtD
Glimepiride—Anaphylactic shock—Epirubicin—testicular cancer	0.000949	0.000949	CcSEcCtD
Glimepiride—Hypotension—Methotrexate—testicular cancer	0.000948	0.000948	CcSEcCtD
Glimepiride—Loss of consciousness—Doxorubicin—testicular cancer	0.000946	0.000946	CcSEcCtD
Glimepiride—Shock—Epirubicin—testicular cancer	0.000934	0.000934	CcSEcCtD
Glimepiride—Convulsion—Doxorubicin—testicular cancer	0.000932	0.000932	CcSEcCtD
Glimepiride—Thrombocytopenia—Epirubicin—testicular cancer	0.000929	0.000929	CcSEcCtD
Glimepiride—Hypertension—Doxorubicin—testicular cancer	0.000929	0.000929	CcSEcCtD
Glimepiride—Tachycardia—Epirubicin—testicular cancer	0.000926	0.000926	CcSEcCtD
Glimepiride—Hyperhidrosis—Epirubicin—testicular cancer	0.000918	0.000918	CcSEcCtD
Glimepiride—Insomnia—Methotrexate—testicular cancer	0.000917	0.000917	CcSEcCtD
Glimepiride—Anxiety—Doxorubicin—testicular cancer	0.000913	0.000913	CcSEcCtD
Glimepiride—Paraesthesia—Methotrexate—testicular cancer	0.000911	0.000911	CcSEcCtD
Glimepiride—Anorexia—Epirubicin—testicular cancer	0.000905	0.000905	CcSEcCtD
Glimepiride—Dyspnoea—Methotrexate—testicular cancer	0.000904	0.000904	CcSEcCtD
Glimepiride—Somnolence—Methotrexate—testicular cancer	0.000902	0.000902	CcSEcCtD
Glimepiride—Dry mouth—Doxorubicin—testicular cancer	0.000896	0.000896	CcSEcCtD
Glimepiride—Dyspepsia—Methotrexate—testicular cancer	0.000893	0.000893	CcSEcCtD
Glimepiride—Hypotension—Epirubicin—testicular cancer	0.000887	0.000887	CcSEcCtD
Glimepiride—Confusional state—Doxorubicin—testicular cancer	0.000886	0.000886	CcSEcCtD
Glimepiride—Decreased appetite—Methotrexate—testicular cancer	0.000882	0.000882	CcSEcCtD
Glimepiride—Anaphylactic shock—Doxorubicin—testicular cancer	0.000878	0.000878	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000876	0.000876	CcSEcCtD
Glimepiride—Fatigue—Methotrexate—testicular cancer	0.000874	0.000874	CcSEcCtD
Glimepiride—Shock—Doxorubicin—testicular cancer	0.000864	0.000864	CcSEcCtD
Glimepiride—Thrombocytopenia—Doxorubicin—testicular cancer	0.00086	0.00086	CcSEcCtD
Glimepiride—Insomnia—Epirubicin—testicular cancer	0.000858	0.000858	CcSEcCtD
Glimepiride—Tachycardia—Doxorubicin—testicular cancer	0.000857	0.000857	CcSEcCtD
Glimepiride—Paraesthesia—Epirubicin—testicular cancer	0.000852	0.000852	CcSEcCtD
Glimepiride—Hyperhidrosis—Doxorubicin—testicular cancer	0.000849	0.000849	CcSEcCtD
Glimepiride—Dyspnoea—Epirubicin—testicular cancer	0.000846	0.000846	CcSEcCtD
Glimepiride—Somnolence—Epirubicin—testicular cancer	0.000844	0.000844	CcSEcCtD
Glimepiride—Anorexia—Doxorubicin—testicular cancer	0.000837	0.000837	CcSEcCtD
Glimepiride—Feeling abnormal—Methotrexate—testicular cancer	0.000836	0.000836	CcSEcCtD
Glimepiride—Dyspepsia—Epirubicin—testicular cancer	0.000836	0.000836	CcSEcCtD
Glimepiride—Gastrointestinal pain—Methotrexate—testicular cancer	0.000829	0.000829	CcSEcCtD
Glimepiride—Decreased appetite—Epirubicin—testicular cancer	0.000825	0.000825	CcSEcCtD
Glimepiride—Hypotension—Doxorubicin—testicular cancer	0.000821	0.000821	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000819	0.000819	CcSEcCtD
Glimepiride—Fatigue—Epirubicin—testicular cancer	0.000818	0.000818	CcSEcCtD
Glimepiride—Urticaria—Methotrexate—testicular cancer	0.000806	0.000806	CcSEcCtD
Glimepiride—Abdominal pain—Methotrexate—testicular cancer	0.000802	0.000802	CcSEcCtD
Glimepiride—Insomnia—Doxorubicin—testicular cancer	0.000794	0.000794	CcSEcCtD
Glimepiride—Paraesthesia—Doxorubicin—testicular cancer	0.000789	0.000789	CcSEcCtD
Glimepiride—Dyspnoea—Doxorubicin—testicular cancer	0.000783	0.000783	CcSEcCtD
Glimepiride—Feeling abnormal—Epirubicin—testicular cancer	0.000782	0.000782	CcSEcCtD
Glimepiride—Somnolence—Doxorubicin—testicular cancer	0.000781	0.000781	CcSEcCtD
Glimepiride—Gastrointestinal pain—Epirubicin—testicular cancer	0.000776	0.000776	CcSEcCtD
Glimepiride—Dyspepsia—Doxorubicin—testicular cancer	0.000773	0.000773	CcSEcCtD
Glimepiride—Decreased appetite—Doxorubicin—testicular cancer	0.000763	0.000763	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000758	0.000758	CcSEcCtD
Glimepiride—Fatigue—Doxorubicin—testicular cancer	0.000757	0.000757	CcSEcCtD
Glimepiride—Urticaria—Epirubicin—testicular cancer	0.000754	0.000754	CcSEcCtD
Glimepiride—Abdominal pain—Epirubicin—testicular cancer	0.00075	0.00075	CcSEcCtD
Glimepiride—Hypersensitivity—Methotrexate—testicular cancer	0.000747	0.000747	CcSEcCtD
Glimepiride—Asthenia—Methotrexate—testicular cancer	0.000728	0.000728	CcSEcCtD
Glimepiride—Feeling abnormal—Doxorubicin—testicular cancer	0.000724	0.000724	CcSEcCtD
Glimepiride—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000718	0.000718	CcSEcCtD
Glimepiride—Pruritus—Methotrexate—testicular cancer	0.000718	0.000718	CcSEcCtD
Glimepiride—Hypersensitivity—Epirubicin—testicular cancer	0.000699	0.000699	CcSEcCtD
Glimepiride—Urticaria—Doxorubicin—testicular cancer	0.000698	0.000698	CcSEcCtD
Glimepiride—Abdominal pain—Doxorubicin—testicular cancer	0.000694	0.000694	CcSEcCtD
Glimepiride—Diarrhoea—Methotrexate—testicular cancer	0.000694	0.000694	CcSEcCtD
Glimepiride—Asthenia—Epirubicin—testicular cancer	0.000681	0.000681	CcSEcCtD
Glimepiride—Pruritus—Epirubicin—testicular cancer	0.000672	0.000672	CcSEcCtD
Glimepiride—Dizziness—Methotrexate—testicular cancer	0.000671	0.000671	CcSEcCtD
Glimepiride—Diarrhoea—Epirubicin—testicular cancer	0.000649	0.000649	CcSEcCtD
Glimepiride—Hypersensitivity—Doxorubicin—testicular cancer	0.000647	0.000647	CcSEcCtD
Glimepiride—Vomiting—Methotrexate—testicular cancer	0.000645	0.000645	CcSEcCtD
Glimepiride—Rash—Methotrexate—testicular cancer	0.00064	0.00064	CcSEcCtD
Glimepiride—Dermatitis—Methotrexate—testicular cancer	0.000639	0.000639	CcSEcCtD
Glimepiride—Headache—Methotrexate—testicular cancer	0.000635	0.000635	CcSEcCtD
Glimepiride—Asthenia—Doxorubicin—testicular cancer	0.00063	0.00063	CcSEcCtD
Glimepiride—Dizziness—Epirubicin—testicular cancer	0.000628	0.000628	CcSEcCtD
Glimepiride—Pruritus—Doxorubicin—testicular cancer	0.000621	0.000621	CcSEcCtD
Glimepiride—Vomiting—Epirubicin—testicular cancer	0.000604	0.000604	CcSEcCtD
Glimepiride—Nausea—Methotrexate—testicular cancer	0.000602	0.000602	CcSEcCtD
Glimepiride—Diarrhoea—Doxorubicin—testicular cancer	0.000601	0.000601	CcSEcCtD
Glimepiride—Rash—Epirubicin—testicular cancer	0.000598	0.000598	CcSEcCtD
Glimepiride—Dermatitis—Epirubicin—testicular cancer	0.000598	0.000598	CcSEcCtD
Glimepiride—Headache—Epirubicin—testicular cancer	0.000595	0.000595	CcSEcCtD
Glimepiride—Dizziness—Doxorubicin—testicular cancer	0.000581	0.000581	CcSEcCtD
Glimepiride—Nausea—Epirubicin—testicular cancer	0.000564	0.000564	CcSEcCtD
Glimepiride—Vomiting—Doxorubicin—testicular cancer	0.000558	0.000558	CcSEcCtD
Glimepiride—Rash—Doxorubicin—testicular cancer	0.000554	0.000554	CcSEcCtD
Glimepiride—Dermatitis—Doxorubicin—testicular cancer	0.000553	0.000553	CcSEcCtD
Glimepiride—Headache—Doxorubicin—testicular cancer	0.00055	0.00055	CcSEcCtD
Glimepiride—Nausea—Doxorubicin—testicular cancer	0.000522	0.000522	CcSEcCtD
